AB
IBIO icon

Amalgamated Bank’s iBio IBIO Stock Holding History

Amalgamated Bank’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-52
Closed -$11K – 3111
2022
Q1 		$11K Sell
52
-4
-7% -$837 ﹤0.01% 2940
2021
Q4 		$15K Sell
56
-2
-3% -$763 ﹤0.01% 2152
2021
Q3 		$31K Sell
58
-3
-5% -$1.87K ﹤0.01% 2152
2021
Q2 		$46K Buy
61
+12
+24% +$8.75K ﹤0.01% 2168
2021
Q1 		$37K Hold
49
– – ﹤0.01% 1589
2020
Q4 		$26K Buy
+49
New +$39.9K ﹤0.01% 1578

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Amalgamated Bank's IBIO Position: Q2 2022 in Review

Amalgamated Bank sold out of iBio (IBIO) in Q2 2022, closing a stake of 52 shares — an estimated $11K sold.

Amalgamated Bank first reported a position in IBIO in Q4 2020 and held it in 6 quarters. The position peaked at $46K in Q2 2021. 53 funds tracked by Wall St. Rank hold IBIO as of Q2 2022.

  • Amalgamated Bank reported no remaining iBio position as of Q2 2022 after selling out during the quarter.
  • Amalgamated Bank sold 52 iBio shares in Q2 2022, an estimated $11K.
  • Amalgamated Bank first reported a position in iBio in Q4 2020 and held it in 6 quarters.
  • Amalgamated Bank's iBio position peaked at $46K in Q2 2021.
  • 53 funds tracked by Wall St. Rank held iBio as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.